DelveInsight has launched a new report on “Post-Traumatic Stress Disorder (PTSD) Market Insights, Epidemiology, and Market Forecast-2032”.
DelveInsight’s “Post-Traumatic Stress Disorder (PTSD) Market Insights, Epidemiology, and Market Forecast-2032″ report offer an in-depth understanding of the Post-Traumatic Stress Disorder (PTSD), historical and forecasted epidemiology as well as the Post-Traumatic Stress Disorder (PTSD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Post-Traumatic Stress Disorder (PTSD) Market Report:
- According to the American Psychiatric Association, PTSD affects approximately 3.5 percent of US adults every year, and an estimated one in 11 people will be diagnosed with PTSD in their lifetime. Women are twice as likely as men to have PTSD.
- The National Comorbidity Survey Replication (NCS-R), shows the past-year prevalence of PTSD among U.S. adults aged 18 or older.
- In the year 2021, the prevalence population cases of PTSD were 13,538.4 thousand (K) cases in the 7MM
- In the year 2021, the gender-specific cases of PTSD were 4,120.3K cases males and for females
- respectively 9,418.1K cases in the 7MM
Request a sample for the Report: https://www.delveinsight.com/sample-request/post-traumatic-stress-disorder-ptsd-market
Key benefits of the report:
- Post-Traumatic Stress Disorder (PTSD) market report covers a descriptive overview and comprehensive insight of the Post-Traumatic Stress Disorder (PTSD) Epidemiology and Post-Traumatic Stress Disorder (PTSD) market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
- The Post-Traumatic Stress Disorder (PTSD) market report provides insights on the current and emerging therapies.
- Post-Traumatic Stress Disorder (PTSD) market report provides a global historical and forecasted market covering drug outreach in 7MM.
- The Post-Traumatic Stress Disorder (PTSD) market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Post-Traumatic Stress Disorder (PTSD) market.
Got queries? Click here to know more about the Post-Traumatic Stress Disorder (PTSD) Market Landscape
Post-Traumatic Stress Disorder (PTSD) Overview:
Post-traumatic stress disorder (PTSD) has been described as “the complex somatic, cognitive, affective, and behavioral effects of psychological trauma.” It is characterized by intrusive thoughts, nightmares, and flashbacks of past traumatic events, avoidance of reminders of the trauma, hyper-vigilance, and sleep disturbance, all of which lead to considerable social, occupational, and interpersonal dysfunction. PTSD symptoms may start within 1 month of a traumatic event, but sometimes symptoms may not appear Until years after the event. These symptoms cause significant problems in social or work situations and Relationships.
To diagnose PTSD, the doctor will likely perform a physical exam to check for medical problems that may be causing the symptoms – a psychological evaluation that includes a discussion of the signs and symptoms and the event or events that led up to them and using the criteria in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).
Post-Traumatic Stress Disorder (PTSD) Symptoms:
The symptoms of Post-traumatic stress disorder (PTSD) include-
- Getting easily startled or frightened
- Trouble while sleeping
- Trouble in concentrating
- Irritability, angry outbursts,s or aggressive behavior
- Short-Term Memory Loss
Post-Traumatic Stress Disorder (PTSD) Market
The dynamics of the Post-Traumatic Stress Disorder (PTSD) market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as BNC210, NYX-783, Brexpiprazole, and others during the forecasted period 2019-2032.
Learn more by requesting for sample @Post-Traumatic Stress Disorder (PTSD) Market Landscape
Post-Traumatic Stress Disorder (PTSD) Pipeline Therapies:
- BNC210
- NYX-783
- Brexpiprazole
- JZP150
- Orvepitant
- Topiramate
Post-Traumatic Stress Disorder (PTSD) Pipeline Key Companies:
- Otsuka Pharmaceutical
- Marinus Pharmaceuticals
- Jazz Pharmaceuticals
- Pfizer
- Forest Laboratories
- Janssen Pharmaceuticals
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Post-Traumatic Stress Disorder (PTSD) Patient Share (%) Overview at a Glance
5. Post-Traumatic Stress Disorder (PTSD) Market Overview at a Glance
6. Post-Traumatic Stress Disorder (PTSD) Disease Background and Overview
7. Post-Traumatic Stress Disorder (PTSD) Epidemiology and Patient Population
8. Country-Specific Patient Population of Post-Traumatic Stress Disorder (PTSD)
9. Post-Traumatic Stress Disorder (PTSD) Current Treatment and Medical Practices
10. Unmet Needs
11. Post-Traumatic Stress Disorder (PTSD) Emerging Therapies
12. Post-Traumatic Stress Disorder (PTSD) Market Outlook
13. Country-Wise Post-Traumatic Stress Disorder (PTSD) Market Analysis (2018–2030)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Post-Traumatic Stress Disorder (PTSD) Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Click here to read more about Post-Traumatic Stress Disorder (PTSD) Market Outlook 2032
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: +91 9568243403
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com